These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 33072222)

  • 21. Epitope Classification and RBD Binding Properties of Neutralizing Antibodies Against SARS-CoV-2 Variants of Concern.
    Deshpande A; Harris BD; Martinez-Sobrido L; Kobie JJ; Walter MR
    Front Immunol; 2021; 12():691715. PubMed ID: 34149735
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel screening strategy of anti-SARS-CoV-2 drugs via blocking interaction between Spike RBD and ACE2.
    Wang X; Yang C; Sun Y; Sui X; Zhu T; Wang Q; Wang S; Yang J; Yang W; Liu F; Zhang M; Wang Y; Luo Y
    Environ Int; 2021 Feb; 147():106361. PubMed ID: 33401173
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Computational Mutagenesis at the SARS-CoV-2 Spike Protein/Angiotensin-Converting Enzyme 2 Binding Interface: Comparison with Experimental Evidence.
    Laurini E; Marson D; Aulic S; Fermeglia A; Pricl S
    ACS Nano; 2021 Apr; 15(4):6929-6948. PubMed ID: 33733740
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An Active Site Inhibitor Induces Conformational Penalties for ACE2 Recognition by the Spike Protein of SARS-CoV-2.
    Williams-Noonan BJ; Todorova N; Kulkarni K; Aguilar MI; Yarovsky I
    J Phys Chem B; 2021 Mar; 125(10):2533-2550. PubMed ID: 33657325
    [TBL] [Abstract][Full Text] [Related]  

  • 25. S494 O-glycosylation site on the SARS-CoV-2 RBD affects the virus affinity to ACE2 and its infectivity; a molecular dynamics study.
    Rahnama S; Azimzadeh Irani M; Amininasab M; Ejtehadi MR
    Sci Rep; 2021 Jul; 11(1):15162. PubMed ID: 34312429
    [TBL] [Abstract][Full Text] [Related]  

  • 26.
    Tiwari V
    Biol Open; 2020 Oct; 9(10):. PubMed ID: 32878881
    [TBL] [Abstract][Full Text] [Related]  

  • 27. COVID-19 Coronavirus spike protein analysis for synthetic vaccines, a peptidomimetic antagonist, and therapeutic drugs, and analysis of a proposed achilles' heel conserved region to minimize probability of escape mutations and drug resistance.
    Robson B
    Comput Biol Med; 2020 Jun; 121():103749. PubMed ID: 32568687
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Computational Alanine Scanning and Structural Analysis of the SARS-CoV-2 Spike Protein/Angiotensin-Converting Enzyme 2 Complex.
    Laurini E; Marson D; Aulic S; Fermeglia M; Pricl S
    ACS Nano; 2020 Sep; 14(9):11821-11830. PubMed ID: 32833435
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potential chimeric peptides to block the SARS-CoV-2 spike receptor-binding domain.
    Barh D; Tiwari S; Silva Andrade B; Giovanetti M; Almeida Costa E; Kumavath R; Ghosh P; Góes-Neto A; Carlos Junior Alcantara L; Azevedo V
    F1000Res; 2020; 9():576. PubMed ID: 32802318
    [No Abstract]   [Full Text] [Related]  

  • 30. Biomechanical characterization of SARS-CoV-2 spike RBD and human ACE2 protein-protein interaction.
    Cao W; Dong C; Kim S; Hou D; Tai W; Du L; Im W; Zhang XF
    Biophys J; 2021 Mar; 120(6):1011-1019. PubMed ID: 33607086
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insights on SARS-CoV-2 Molecular Interactions With the Renin-Angiotensin System.
    Costa LB; Perez LG; Palmeira VA; Macedo E Cordeiro T; Ribeiro VT; Lanza K; Simões E Silva AC
    Front Cell Dev Biol; 2020; 8():559841. PubMed ID: 33042994
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular basis for drug repurposing to study the interface of the S protein in SARS-CoV-2 and human ACE2 through docking, characterization, and molecular dynamics for natural drug candidates.
    Alazmi M; Motwalli O
    J Mol Model; 2020 Nov; 26(12):338. PubMed ID: 33175236
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Angiotensin-Converting Enzyme 2 (ACE2) in the Pathogenesis of ARDS in COVID-19.
    Kuba K; Yamaguchi T; Penninger JM
    Front Immunol; 2021; 12():732690. PubMed ID: 35003058
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Leaving no stone unturned: Allosteric targeting of SARS-CoV-2 spike protein at putative druggable sites disrupts human angiotensin-converting enzyme interactions at the receptor binding domain.
    Olotu FA; Omolabi KF; Soliman MES
    Inform Med Unlocked; 2020; 21():100451. PubMed ID: 33083517
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Computer-aided drug design against spike glycoprotein of SARS-CoV-2 to aid COVID-19 treatment.
    Shehroz M; Zaheer T; Hussain T
    Heliyon; 2020 Oct; 6(10):e05278. PubMed ID: 33083627
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis, crystal structure elucidation, DFT analysis, drug-likeness and ADMET evaluation and molecular docking studies of triazole derivatives: Binary inhibition of spike protein and ACE2 receptor protein of COVID-19.
    Murugavel S; Vasudevan P; Chandrasekaran R; Archana V; Ponnuswany A
    J Chin Chem Soc; 2022 Jun; 69(6):884-900. PubMed ID: 35941959
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Understanding the role of galectin inhibitors as potential candidates for SARS-CoV-2 spike protein:
    Sethi A; Sanam S; Munagalasetty S; Jayanthi S; Alvala M
    RSC Adv; 2020 Aug; 10(50):29873-29884. PubMed ID: 35518264
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of inhibitors against SARS-CoV-2 variants of concern using virtual screening and metadynamics-based enhanced sampling.
    Mandal N; Rath SL
    Chem Phys; 2023 Sep; 573():111995. PubMed ID: 37342284
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting the SARS-CoV-2-spike protein: from antibodies to miniproteins and peptides.
    Pomplun S
    RSC Med Chem; 2020 Dec; 12(2):197-202. PubMed ID: 34041482
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SARS-CoV-2 Spike Protein Post-Translational Modification Landscape and Its Impact on Protein Structure and Function via Computational Prediction.
    Liang B; Zhu Y; Shi W; Ni C; Tan B; Tang S
    Research (Wash D C); 2023 Mar; 6():0078. PubMed ID: 36930770
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.